Paragon 28, Inc. (FNA)
NYSE: FNA · IEX Real-Time Price · USD
7.66
-0.31 (-3.89%)
May 17, 2024, 4:00 PM EDT - Market closed
Paragon 28 Market Cap
Paragon 28 has a market cap or net worth of $635.41 million as of May 17, 2024. Its market cap has decreased by -57.42% in one year.
Market Cap
635.41M
Enterprise Value
687.67M
1-Year Change
-57.42%
Ranking
Category
Stock Price
$7.66
Market Cap Chart
Since the IPO on October 15, 2021, Paragon 28's market cap has decreased from $1.20B to $635.41M, a decrease of -47.19%. That is a compound annual growth rate of -21.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 635.40M | -3.89% |
May 16, 2024 | 661.10M | -1.61% |
May 15, 2024 | 671.90M | 2.02% |
May 14, 2024 | 658.60M | -2.10% |
May 13, 2024 | 672.70M | 4.64% |
May 10, 2024 | 642.90M | -6.05% |
May 9, 2024 | 684.30M | -13.16% |
May 8, 2024 | 788.00M | -9.66% |
May 7, 2024 | 872.30M | -1.31% |
May 6, 2024 | 883.90M | 1.33% |
May 3, 2024 | 872.30M | 7.78% |
May 2, 2024 | 809.30M | -0.92% |
May 1, 2024 | 816.80M | 6.94% |
Apr 30, 2024 | 763.80M | 1.10% |
Apr 29, 2024 | 755.50M | 3.64% |
Apr 26, 2024 | 729.00M | -1.88% |
Apr 25, 2024 | 743.00M | -6.95% |
Apr 24, 2024 | 798.50M | -4.08% |
Apr 23, 2024 | 832.50M | 2.65% |
Apr 22, 2024 | 811.00M | -0.10% |
Apr 19, 2024 | 811.80M | 1.55% |
Apr 18, 2024 | 799.40M | -0.82% |
Apr 17, 2024 | 806.00M | 0.94% |
Apr 16, 2024 | 798.50M | -1.94% |
Apr 15, 2024 | 814.30M | -4.10% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Definitive Healthcare | 648.64M |
GH Research | 647.23M |
Zymeworks | 644.12M |
Mineralys Therapeutics | 641.96M |
Weave Communications | 641.53M |
Savara | 633.60M |
Pharming Group | 626.30M |
ORIC Pharmaceuticals | 620.62M |